Related Experiment Video
Updated: Jan 31, 2026

Measurements of CO2 Fluxes at Non-Ideal Eddy Covariance Sites
Published on: June 24, 2019
Covariates in Pharmacometric Repeated Time-to-Event Models: Old and New (Pre)Selection Tools
Sebastiaan C Goulooze1, Elke H J Krekels1, Thomas Hankemeier1
1Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Room number 0.2.11, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Abstract:
During covariate modeling in pharmacometrics, computational time can be reduced by using a fast preselection tool to identify a subset of promising covariates that are to be tested with the more computationally demanding likelihood ratio test (LRT), which is considered to be the standard for covariate selection. There is however a lack of knowledge on best practices for covariate (pre)selection in pharmacometric repeated time-to-event (RTTE) models. Therefore, we aimed to systematically evaluate the performance of three covariate (pre)selection tools for RTTE models: the likelihood ratio test (LRT), the empirical Bayes estimates (EBE) test, and a novel Schoenfeld-like residual test. This was done in simulated datasets with and without a "true" time-constant covariate, and both in the presence and absence of high EBE shrinkage. In scenarios with a "true" covariate effect, all tools had comparable power to detect this effect. In scenarios without a "true" covariate effect, the false positive rates of the LRT and the Schoenfeld-like residual test were slightly inflated to 5.7% and 7.2% respectively, while the EBE test had no inflated false positive rate. The presence of high EBE shrinkage (> 40%) did not affect the performance of any of the covariate (pre)selection tools. We found the EBE test to be a fast and accurate tool for covariate preselection in RTTE models. The novel Schoenfeld-like residual test proposed here had a similar performance in the tested scenarios and might be applied more readily to time-varying covariates, such as drug concentration and dynamic biomarkers.
Related Concept Videos
Theory of Attribution II: Kelley's Covariation Theory
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Integration of Synaptic Events
What is Natural Selection?

